Gerald Henry Nabozny

Title: Gerald Henry Nabozny: Innovator in Anti-IL-23 Antibodies

Introduction

Gerald Henry Nabozny is a notable inventor based in New Milford, Connecticut. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for medical challenges, showcasing his dedication to advancing healthcare.

Latest Patents

Gerald Henry Nabozny holds a patent for anti-IL-23 antibodies. The present invention relates to anti-IL-23p19 binding compounds, specifically new humanized anti-IL-23p19 antibodies. This patent also includes pharmaceutical compositions and therapeutic and diagnostic methods for utilizing these antibodies effectively.

Career Highlights

Nabozny is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout his career, Gerald has collaborated with esteemed colleagues, including Torsten Schultz-Fademrecht and Elaine Ee-Ling Wang. These partnerships have contributed to the advancement of his research and the successful development of new therapeutic solutions.

Conclusion

Gerald Henry Nabozny's work in the field of anti-IL-23 antibodies exemplifies his commitment to innovation in biotechnology. His contributions are paving the way for new treatments that can significantly impact patient care.